The Promise and the Peril of AI-Driven Diagnostics
Artificial intelligence is transforming healthcare globally, enabling predictive analytics, medical imaging analysis, and automated diagnostic systems. In the Philippines, cardiologists and imaging specialists are concentrated in urban centers, creating a geographic access gap that AI-enhanced tools could help bridge. AI-enhanced electrocardiography and point-of-care imaging have demonstrated sensitivities above 97 percent for high-risk hypertrophic cardiomyopathy features, raising the prospect of early screening in primary care facilities and community hospitals.
But the integration of AI into clinical environments is not without risk. A 2025 literature review published in IEEE Xplore analyzed 21 peer-reviewed sources and identified four dominant focus areas: AI applications in healthcare, cybersecurity and privacy, integration of emerging technologies, and explainable and ethical AI. The review found that the literature predominantly emphasizes theoretical models, with limited practical deployment. Significant gaps exist in implementation, data governance, ethical alignment, and infrastructure adaptation — particularly in applying global AI frameworks to local contexts.
Why Genomic Data Requires Special Governance
Genomic data is fundamentally different from other categories of health information. It is immutable, uniquely identifying, and inherently relational — a single individual’s genome contains information about their biological relatives, whether or not those relatives have consented to testing. In a country like the Philippines, where extended family structures are central to social organization, the privacy implications of genomic data sharing are particularly acute.
The Philippines AI in Genomics Market report notes that genomics AI applications are limited by the lack of extensive genomic databases representative of the Filipino population, and that data privacy concerns and ethical issues related to genetic information complicate data sharing. The country is one of two ASEAN nations participating in the Cross-Border Privacy Rules system, and the Department of Health and PhilHealth are working to integrate medical data for efficient service delivery. But the operational guidelines for genomic data sharing, storage, and secondary research use remain under development.
Cardiomyopathy as a Test Case for AI Governance
The application of AI to cardiomyopathy diagnosis in the Philippines illustrates both the potential and the governance challenge. Cardiomyopathies — including hypertrophic, dilated, and arrhythmogenic subtypes — are leading causes of sudden cardiac death, a burden that is rising in the Philippines. AI models can integrate genetic, imaging, and clinical data to predict risk and guide timely interventions such as implantable cardioverter-defibrillators.
However, as one letter to the editor in Heart Rhythm O2 argued, policy frameworks must address data privacy, algorithmic transparency, and validation in Filipino populations to prevent clinical bias. AI models trained predominantly on European or North American datasets may perform poorly when applied to Filipino patients, whose genetic ancestry and environmental exposures differ substantially. Future research in the Philippines should validate existing AI-based cardiomyopathy models using local datasets to ensure accuracy across ethnic and environmental variations.
The Workforce and Infrastructure Dimension
The governance challenge is compounded by resource constraints. The Philippines faces shortages of clinician-scientists, geneticists, and genetic counselors — the very professionals who would be responsible for interpreting AI-generated risk scores and communicating them to patients. Without adequate human oversight, AI-driven diagnostics risk automating bias rather than mitigating it.
The Universal Healthcare Act and the National AI Strategy (NAIS PH) provide a policy foundation, but the Philippines currently has no special laws or regulations governing the use of AI in healthcare. The IEEE review called for localized pilot programs, culturally relevant ethical standards, and improved cybersecurity systems to inform national policy and offer actionable guidance for responsible AI integration.
The question is not whether AI will play a role in Philippine precision medicine — it already does. The question is whether the governance frameworks, workforce capacity, and ethical safeguards will develop quickly enough to ensure that AI expands access and improves outcomes rather than deepening existing inequities.
